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INTRODUCTION
Vimentin is a type III intermediate filament protein normally
expressed in cells of mesenchymal origin (Steinert and Roop,
1988). However, vimentin expression has been described in
epithelial cells involved in pathological or physiological
processes which require epithelial cell migration. Accordingly,
accumulating data now support the concept that epithelial cell
acquisition of migratory and/or invasive properties is
associated with the loss of epithelial characteristics and the
gain of mesenchymal properties, a phenomenon referred to as
epithelial-to-mesenchymal transition (EMT). Several other
groups of molecules (including cell-cell adhesion molecules,
cell-substrate adhesion molecules, proteases, transcription
factors...) have been implicated in the EMT associated with
different physiological or pathological processes (Savagner et
al., 1994; Guarino, 1995; Hay, 1995; Gilles and Thompson,
1996). More specifically, vimentin has been described in
epithelial cells involved in embryological and organogenesis
processes (Guarino, 1995; Hay, 1995), wound healing
(SundarRaj et al., 1992), placentation (Nawrocki et al., 1997)
or tumor invasion (Ramaekers et al., 1983; Savagner et al.,
1994; Guarino, 1995; Gilles and Thompson, 1996; Gilles et al.,
1996). Similarly, vimentin expression has been detected in
several human epithelial tumor cell lines. Comparative studies
have nevertheless shown that vimentin expression is restricted
to those cell lines displaying high invasive abilities, suggesting
that vimentin is related to high invasive abilities rather than
being non-specifically induced by culture conditions (Sommers
et al., 1989, 1992; Gilles et al., 1994a,b; Gilles and Thompson,
1996; Hendrix et al., 1996; Polette et al., 1998). Furthermore,
vimentin antisense transfection into invasive, vimentin-positive
breast carcinoma MDA-MB-231 cells decreased their in vitro
invasive properties, thereby suggesting that vimentin plays a
functional role in invasion (Hendrix et al., 1997). However,
because it is difficult to identify a migratory cell in vivo and
because vimentin expression is stable in most human cell lines,
it is still unclear whether or not vimentin expression is
associated with the migratory status.
Indeed, the sequence of events implicated in the EMT and
its regulation (induction or repression) are still poorly
understood. This lack of information partly results from the
absence of adequate in vitro human models allowing the study
of EMT dynamics. Indeed, EMT has been primarily induced
by various means and studied in two cellular models: Mardin-
Darby canine kidney (MDCK) cells (Weidner et al., 1990;
Behrens et al., 1993) and rat bladder carcinoma NBTII cells
(Boyer et al., 1989; Vallés et al., 1990; Savagner et al., 1994).
Vimentin expression was for instance induced in NBTII cells
in response to growth factors (such as acidic fibroblast growth
factor or hepatocyte growth factor) or several collagen types
(Boyer et al., 1989; Zuk et al., 1989; Tucker et al., 1990; Vallés
et al., 1990; Savagner et al., 1994). Transfection of MDCK
cells with the SV40 large T antigen has also been shown to
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Vimentin expression in human mammary epithelial
MCF10A cells was examined as a function of their
migratory status using an in vitro wound-healing model.
Analysis of the trajectories of the cells and their migratory
speeds by time lapse-video microscopy revealed that
vimentin mRNA and protein expression were exclusively
induced in cells at the wound’s edge which were actively
migrating towards the center of the lesion. Actin labeling
showed the reorganization of actin filaments in cells at the
wound’s edge which confirmed the migratory phenotype of
this cell subpopulation. Moreover, the vimentin protein
disappeared when the cells became stationary after wound
closure. Using cells transfected with the vimentin promoter
controlling the green fluorescent protein gene, we also
demonstrated the specific activation of the vimentin
promoter in the migratory cells at the wound’s edge.
Transfection of the antisense vimentin cDNA into MCF10A
cells clearly reduced both their ability to express vimentin
and their migratory speed. Taken together, these
observations demonstrate that vimentin is transiently
associated with, and could be functionally involved in, the
migratory status of human epithelial cells.
Key words: Vimentin, Migration, MCF10A, EMT, Epithelial-to-
mesenchymal transition, Epithelial cell
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generate a stable EMT-derived phenotype with enhanced
vimentin expression (Martel et al., 1997). Using a mouse
mammary epithelial cell model, Lochter et al. (1997) have
also demonstrated that the transfection of the matrix
metalloproteinase stromelysin-1 induces an EMT, including
vimentin upregulation, associated with an invasive behaviour.
Data concerning the dynamics and regulation of cell
migration/invasion as a function of vimentin expression in
human cells are however scarce since most human cell lines
display relatively stable phenotypes and cannot be easily
induced to express invasive/EMT-derived properties. Most data
on human epithelial cell migration have therefore been
obtained on primary cells, which retain more plasticity than
most human cell lines and can be induced to migrate under
conditions mimicking wound-healing or organogenesis. Thus,
vimentin expression has been described in human
keratinocytes involved in the outgrowth of keratinocyte sheets
or in the leading edge of a wounded monolayer (Biddle and
Spandau, 1996). Similarly, we reported vimentin expression in
normal human bronchial cells studied in an in vitro wound-
healing model (Buisson et al., 1996). However, until now, a
human model enabling vimentin expression to be studied as a
function of the migratory status was lacking. Thus, vimentin
association with and functional contribution to cell migration
remain to be elucidated.
In the present study, we used the human breast cell line
MCF10A in an in vitro wound-healing system to establish a
human model of EMT to study the dynamics of vimentin
expression as a function of the migratory status. We used time-
lapse video microscopy to quantify cell migration and herein
report the transient association between vimentin expression
and cell migration. We also used antisense transfection
strategies which demonstrated a functional contribution of
vimentin to epithelial cell acquisition of migratory properties. 
MATERIALS AND METHODS
Cell culture
Human mammary epithelial MCF10A cells were obtained from the
American Type Culture Collection (Rockville, MD). Their growth
medium was composed of HAM F12 and Dulbecco modified Eagle’s
medium (DMEM) 1:3 (v/v) supplemented with 20 m g/ml of adenine,
5 m g/ml of insulin, 0.5 m g/ml of hydrocortisone, 2 ng/ml of EGF, 5
m g/ml of transferrin, 1.5 ng/ml of triiodothyronine and 10% FCS. The
different MCF10A transfectants generated in this study were
cultivated in the same medium. MDA-MB-231 human breast
mammary carcinoma cells were also obtained from the American
Type Culture Collection and were maintained in DMEM
supplemented with 10% FCS. Primary human airway cells were
prepared as previously described (Zahm et al., 1997; Legrand et al.,
1999). Cultures were maintained at 37°C and were Mycoplasma-free,
as assessed with the Genprobe kit (Genprobe, San Diego, CA). All
chemicals and culture media were purchased from Sigma Chemical
Co. (St Louis, MO), Life Technologies (Gaithersburg, MD) or
Boehringer (Boehringer Mannheim, Mannheim, Germany).
Vector constructs
The vimentin promoter-EGFP-1 vector (VP-EGFP) was constructed
by cloning an EcoRI-BamHI 1.5-kb fragment of the human vimentin
5¢ -upstream region into the multiple cloning site of the promoter-less
EGFP-1 vector (Clonetech, Palo Alto, CA), containing a red-shifted
variant of the green fluorescent protein (GFP) encoding gene as the
reporter gene. This fragment, described and cloned as the vimentin
promoter (Rittling and Baserga, 1987), was isolated from
pG4F1EM1.5, kindly provided by Dr Rittling (Temple University
Medical School, Philadelphia, PA). The pEGFP-1 vector was used as
the control vector.
The vimentin sense and antisense expression vectors (pIRES-VimS
and pIRES-VimAS, respectively) were constructed by cloning the
sense or antisense orientated 1.8-kb human vimentin cDNA into the
EcoRI site of the pIRESpuro vector (Clonetech). The human vimentin
cDNA (Sommers et al., 1989, 1992) was obtained from the EcoRI
digestion of pCMV-VIM kindly provided by Dr Gelmann (Lombardi
Cancer Center, Georgetown University, Washington, DC). The
pIRES-EGFP vector, containing the EGFP reporter gene cloned into
pIRESpuro was used as a control vector. The pIRES vector contains
the internal ribosome entry site from the encephalomyocarditis virus
which allows the translation of two open reading frames from a single
mRNA. The mRNA generated from the pIRES-VimS and pIRES-
VimAS constructs are therefore bicistronic and easily distinguishable
by northern blotting from the endogenous vimentin mRNA because
of their bigger size.
Transfection
Stable transfection of MCF10A cells were performed with the
different vector constructs in serum-free medium at 200 V and 960
m F using a gene pulser system (Bio-Rad, Richmond, CA). The
transfected populations were then subjected to a selective pressure
with geneticin G418 (for the EGFP-1 constructs) or puromycin (for
the pIRESpuro constructs). For each transfection, several clones and
several pooled transfected populations were isolated and
characterized.
Growth curves
5· 104 cells per well (in triplicates) were plated into 24-well plates in
growth medium then sonicated in PBS at different time intervals (3,
24, 48, 72, 96 hours and 7 days). Fluorimetric DNA titration was
performed on sonicated cells and used as an indicator of cell density.
The doubling time was estimated on the linear part of the curves.
In vitro wound induction procedure and the ring system
Glass coverslips (22 mm in diameter) were incubated for 3 hours
with a solution containing 250 m g/ml of cyanamide (Sigma) and 250
m g/ml of collagen type I extracted from rat tails. The collagen-
coated coverslips were then allowed to dry under a Laminar-flow
hood. Twenty-four hours before wound induction, 5 · 105 cells were
seeded in growth medium on these collagen-coated glass coverslips.
An in vitro wound was then created in the middle of the monolayer
with a 1 m l drop of 1 M NaOH which was immediately and
extensively washed out with PBS (as described by Zahm et al., 1997;
Legrand et al., 1999). Cells were then covered with the appropriate
medium: growth medium for regular experiments or FCS+EGF-free
growth medium for EGF induction experiments. For these latter,
human recombinant EGF (Boehringer) was added to the medium at
a final concentration of 20 ng/ml. These cultures were then
processed for the quantifications of wound closure, and cell
migration speeds and cell trajectories, and immunolabeling or in situ
hybridization.
An alternative migration-induction procedure was also used, which
we will refer to as the ring system; it consists in plating 5 · 104 cells
inside a 6-mm glass ring placed in the middle of a collagen-coated
coverslip. Twenty-four hours after plating, the glass ring was removed
and the cells were covered with growth medium. In this model, the
cells migrate as an outgrowth from the confluent area initially
delimited by the ring. As described below, the migratory speeds and
trajectories of the cell nuclei can be quantified and analyzed. This ring
system was used to study sense and antisense transfectants because
this procedure is easier to handle when a large number of cell lines
are to be examined. 
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Quantification of the wound closure
Every 24 hours after wound induction, the monolayers were placed
on the stage of an inverted microscope (Nikon TMS-F, Tokyo, Japan),
connected to a video CCD camera (Cohu 4700, San Diego, CA) and
a video monitor (PVM 1371, Sony, Japan), so as to visualize the
wound’s edge and measure the wound’s area.
Quantification of cell migration speeds and trajectories
Wounded monolayers were incubated with a fluorescent nuclear dye
(Hoechst 33258, Molecular Probes, Eugene, OR). They were then
placed in the environmental chamber (37°C, 5% CO2) of a Zeiss IM35
inverted microscope (Zeiss, Oberkochen, Germany) equipped with an
epifluorescence illumination source (excitation filter at 360 nm;
emission filter at 510 nm) and a low level SIT camera (Lhesa 4036)
controlled by a microcomputer (SparcClassic Workstation). An image
was collected every 10 or 15 minutes during 1 hour. Cell migration
was characterized and quantified using a previously described software
program (Zahm et al., 1997) that measures the nuclei trajectories
within the hour of observation as well as the cell migration speed. 
Immunofluorescence
Monolayers were fixed with cold methanol (or 4% paraformaldehyde
in PBS if GFP-vimentin covisualization was needed) for 10 minutes,
saturated for 30 minutes with 3% BSA in PBS and then processed for
single vimentin or double vimentin-actin immunolabeling. 
For vimentin labeling, monolayers were successively (after
intermediate washes) incubated for 1 hour with a monoclonal
antibody to vimentin (Dako, Glostrup, Denmark), a biotinylated-
sheep anti-mouse antibody (Amersham, Aylesbury, UK) and Texas
Red-conjugated streptavidin (Amersham) for 30 minutes. Nuclei were
labeled with 4¢ ,6-diamidino-2-phenylindole (DAPI; 1 m g/ml) for 20
minutes. The coverslips were then mounted with Citifluor antifading
solution (Agar, UK) onto glass slides and the slides were observed
under a Zeiss fluorescence microscope. 
For vimentin-actin double immunolabeling, monolayers were
successively (with intermediate washes) incubated with a rabbit
anti-actin antibody (Sigma) for 1 hour, then with fluorescein
isothiocyanate (FITC)-conjugated swine-anti rabbit IgG (Dako) and
CY3-conjugated anti-vimentin monoclonal antibody (Dako). The cell
nuclei were labeled with DAPI for 20 minutes before they were
mounted and observed as described above.
BrdU incorporation, detection and evaluation of cell
proliferation
Cell monolayers were incubated with BrdU (5-bromo-2¢ -deoxyuridine:
100 m M in serum-free medium) for 30 minutes before they were fixed
in cold methanol for 10 minutes. Cells were then exposed to HCl (2
N) for 20 minutes to ensure DNA denaturation and neutralized by
several washes with sodium tetraborate (0.1 M, pH 8.5) and with PBS.
For BrdU detection, monolayers were then incubated 30 minutes with
an FITC-conjugated anti-BrdU antibody (Becton Diskinson, San Jose,
CA). For vimentin-BrdU double immunolabeling, monolayers were
successively labeled for vimentin then for BrdU. The cell nuclei were
then labeled with DAPI for 20 minutes before the coverslips were
mounted and observed as described above. For the evaluation of the
percentage of BrdU incorporating cells in the ring system, slides were
observed under a fluorescent microscope (Olympus, Melville, NY)
equipped with a Sony 3CCD color video camera (DXC-9100P, Sony)
and the nuclei (blue for DAPI and green for BrdU) were quantified
using an Olympus microimage analysis software (version 3.0.1). 5
fields (magnification: · 20) at the edge of the outgrowth were
quantified for each cell line.
In situ hybridization
The wounded cultures were fixed for 10 minutes in 4%
paraformaldehyde in PBS, dehydrated in ethanol 50% and 70%,
rehydrated and treated with 0.2 N HCl for 20 minutes at room
temperature. They were then washed in 2· SSC, acetylated in 0.25%
acetic anhydride in 0.1 M triethanolamine for 10 minutes and hybridized
overnight with 35S-labeled vimentin antisense RNA transcripts. These
probes were prepared from the vimentin cDNA insert which had been
cloned into pGEM3 (kindly provided by Dr Gelmann). The samples
were then treated with RNase (20 m g/ml) for 1 hour at 37°C to remove
the unhybridized probes, washed under stringent conditions and
detected autoradiographically by exposure to D19 emulsion (Kodak,
Rochester, NY) for 15 days. The control slides were treated under the
same conditions but were hybridized with 35S-labeled sense probes.
Northern blotting analyses
Total RNA were isolated from the different cell lines using RNA
instapure (Eurogentec, Seraing, Belgium). Each RNA (10 m g) was
then analyzed by electrophoresis through 1% agarose gels containing
10% formaldehyde and transferred onto nylon membranes
(Amersham). The membranes were then hybridized either with a
vimentin probe generated by PCR using the vimentin cDNA as the
template (from base 866-1190 on the vimentin sequence published by
Ferrari et al. (1986), GenBank accession number M14144) or with a
puromycin probe. Probes were labeled with 32P using a random
priming labeling kit (Boehringer).
Statistical analyses
Data are expressed as means ± standard deviation. Student’s t-test was
used to compare the migration speeds of the cells under various
experimental conditions and to compare the proliferation and BrdU
incorporation ability of the different transfectants. A one-way analysis
of variance (ANOVA) was used to test the effect of vimentin sense or
antisense transfections on both vimentin expression and cell migration
speeds and of vimentin expression on cell migration speeds. A P value
of <0.05 was considered significant. 
RESULTS
In vitro wound healing: a model to visualize and
quantify the migratory status
To study the dynamics of vimentin expression during epithelial
cell migration, we first devised an in vitro wound-healing model
that allowed the regulation and quantification of human
mammary MCF10A cell migration. In this assay, after a circular
wound was created in a confluent monolayer, the cells were
induced to migrate and progressively recolonized the damaged
area. As shown in Fig. 1A and C, wound closure was achieved
96 hours after the wounding procedure in growth medium. Even
though cell proliferation is likely to contribute to the wound
closure, time-lapse video recording over a 1 hour period, allowed
us to quantify the migration speed of individual cells and their
trajectories. Indeed, cells at the wound’s edge were involved in
a directed migration towards the center of the injured area (Fig.
1A) and lamellipodia were clearly identified in migratory cells
(Fig. 1B). The speed of cell movement was directly proportional
to the distance from the wound’s edge (Fig. 2A and B). Cells at
the wound’s edge attained speeds of 40 m m/hour whereas cells
located at 1.2 mm away were basically stationary even though
they moved erratically at about 20 m m/hour. 
Vimentin expression in MCF10A cells is transiently
associated with their migratory status
To assess the potential role of EMT in the acquisition of
migratory properties by MCF10A cells, vimentin expression
in the injured cultures was examined as a function of the
migratory status. We found that vimentin was preferentially
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detected in cells located at the wound’s edge which were
involved in active migration towards the center of the lesion
(Fig. 3A). Time course experiments showed no vimentin in
the cultures at the time of wound induction (0 hours), whereas
its expression was visible in the migrating population (cells
at the wound’s edge) as early as 16 hours after injury.
Vimentin was expressed throughout the migration process but
had disappeared 96 hours after the visual wound closure was
achieved (Fig. 3B), demonstrating that vimentin expression
is inducible and can be reversed once a confluent monolayer
is restored. To evaluate the contribution of transcriptional
regulation of vimentin to this process, in situ hybridization
was performed on the damaged cultures and vimentin mRNA
was detected exclusively in migrating cells at the wound’s
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Fig. 1. In vitro wound-healing model-quantification of the wound closure. (A) Sequential video images of a wounded monolayer of MCF10A
cells, taken immediately, 48, 72 or 96 hours after wounding. (B) Phase-contrast micrographs of MCF10A cells at the wound’s edge. Bar,
40 m m. (C) Time-course measurements of the wounded area.
Fig. 2. Trajectories of the cell nuclei (A) and cell migration
speed (B) in different areas of a wounded culture. (A) Images of
nuclei stained with Hoechst dye and visualized under
epifluorescence illumination (a: at the wound’s edge; b: 1.2 mm
from the edge). Trajectories of 20 randomly selected nuclei
(indicated with a white dot on a and b) were quantified in each
area (c: at the wound’s edge; d: at 1.2 mm from the migration
front). Bars, 80 m m. (B) Speed of the cells in different areas of a
wounded culture (0.4, 0.8 and 1.2 mm from the wound’s edge).
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edge (Fig. 3C). In addition, in MCF10A clones transfected
with the vector containing the vimentin promoter and the GFP
gene as the reporter gene (VP-EGFP), GFP expression
coincided well with the presence of vimentin in cells at the
wound’s edge (Fig. 3D). Nevertheless, GFP was expressed in
more cells than vimentin, emphasizing the delay between
promoter activation and protein synthesis. This finding
demonstrates that the vimentin promoter activates
transcription in migrating cells at the edge of the wound but
not in more distant stationary cells.
To exclude the possibility that the vimentin expressing cells
at the wound edge would represent a subpopulation of
proliferating cells and that vimentin expression could therefore
be associated exclusively to cell proliferation rather than to cell
migration, we analysed vimentin expression in relation with
the expression of the proliferation marker Mib-1 and with
Fig. 3. Specific vimentin expression in MCF10A cells at the wound edge. (A) Vimentin immunolabeling of a wounded culture of MCF10A
cells 48 hours after injury. The distance from the wound’s edge is indicated in mm. Bar, 60 m m. (B) Vimentin immunolabeling of wounded
cultures of MCF10A cells immediately (0h), 24, 48, 72, 96 hours or 8 days (8d) after injury. Bar, 80 m m. (C) In situ hybridization to a wounded
culture of MCF10A cells performed with a vimentin antisense probe 48 hours after injury. Bar, 80 m m. (D) Vimentin (in red) immunolabeling
of a wounded culture of VP-EGFP-transfected cells (GFP in green) 48 hours after injury. Cells expressing both proteins appear in yellow. Bar,
60 m m. (E) Vimentin(red)-BrdU (green) double immunolabeling of a wounded monolayer of MCF10A cells 48hours after wounding. Cells
labelled for both vimentin and BrdU appear in yellow. Bar, 80 m m.
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BrdU-incorporation. This clearly revealed that vimentin
expression is not specifically associated with cell proliferation
since it was restricted to the subpopulation of cells at the
wound edge whereas both BrdU (Fig. 3E) or Mib-1 (data not
shown) labelings were more largely distributed and not limited
to the wound edge.
The association of vimentin with cell migration was further
emphasized by our findings that, within cells at the wound’s
edge, those expressing vimentin migrated significantly more
rapidly that the rare vimentin-negative cells present in this area
(34.2±6.6 vs 23.2±2.8 m m/hour; Fig. 4A,B).
In order to extend our observations to another human
epithelial cell system, we examined vimentin expression as a
function of cell migration in primary human epithelial airway
cells, previously shown to migrate in the wound healing assay
(Zahm et al., 1997; Legrand et al., 1999). We found the same
pattern of vimentin expression in these cells than in the
MCF10A cells with an induction of vimentin in migratory cells
at the wound edge (data not shown). These results also
validated the model of MCF10A cells as an adequate inducible
model to study vimentin induction as a physiological process
associated with cell migration. 
Actin is reorganized in migrating MCF10A cells
Because actin reorganization has been extensively implicated
in lamellipodium extension and cell migration, vimentin-actin
double labeling experiments were performed on injured
MCF10A cultures 48 hours after wound induction.
Reorganization of actin filaments in the migrating vimentin-
expressing cells was observed compared to stationary cells.
The actin filaments were clearly organized as an advancing
front in the lamellipodia of cells at the wound’s edge whereas
they circumscribed stationary cells. The vimentin filaments
extended from the nuclear region to the plasma membrane of
migratory cells (Fig. 5). 
EGF induces vimentin expression and cell migration
Since previous studies of our group have shown that EGF
enhances cell migration of human primary airway cells, we
examined its influence on cell migration and vimentin
expression in our MCF10A model (Zahm et al., 1993). EGF
clearly induced cell migration and promoted wound closure at
about the same rate as the complete growth medium (data not
shown). In contrast, cells cultivated in FCS+EGF-free medium
did not colonize the wounded area (data not shown). In EGF-
treated cultures, vimentin was observed in cells at the wound’s
edge whereas no vimentin filaments were detected in absence
of EGF (Fig. 6). As demonstrated with FCS-treated cultures,
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Fig. 4. Positive correlation between vimentin expression in MCF10A cells and high migration speed. (A, a) Image of Hoechst-labeled nuclei at
the wound’s edge of an injured MCF10A monolayer 48 hours after wounding. Twenty nuclei were selected for the trajectory analyses shown in
A, b. Within these twenty cells, the vimentin-expressing cells have been labeled with a red dot whereas the vimentin negative ones with a blue
dot. (A, c) Double-exposure of the same monolayer after vimentin immunolabeling and DAPI visualization of cell nuclei. Arrows point at
vimentin-negative cells selected for the trajectory analyses. (A, d) Single exposure photo of the vimentin immunolabeling of the same area. Bar,
60 m m. (B) Histogram comparing the migration speeds, calculated from the trajectory analyses shown in (A, b), between vimentin-positive
(Vim+) and vimentin-negative (Vim- ) cells present in the wound edge area.
Fig. 5. Actin reorganization in migrating vimentin-expressing
MCF10A cells at the edge of the wound. (A,B) vimentin (red)-actin
(green) double immunolabeling of a wounded monolayer of
MCF10A cells. Bars: 30 m m (A); 2 m m (B). Cell nuclei, labeled with
DAPI, appear in blue.
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vimentin expression in EGF-treated cells was
therefore also associated with cell migration. In
contrast, the absence of vimentin in FCS+EGF-
deprived wounded cultures, was associated with
significantly lower cell migration speeds (28.8±8.5
vs 8.7±2.3 m m/hour; Fig. 6A,B). Accordingly, the
use of VP-EGFP-transfected clones demonstrated
the activation of the vimentin promoter in cells at the
wound’s edge in EGF-treated but not in EGF-
deprived cultures (data not shown).
Functional contribution of vimentin to
MCF10A cell migration: vimentin sense and
antisense transfections
To examine the possibility that vimentin could play
a functional role in epithelial cell migration, sense
and antisense human vimentin cDNA were
transfected into MCF10A cells. Control cells were
generated by transfection of the pIRES-EGFP vector.
From these transfections, several clones and pooled
populations were isolated and screened for
appropriate vector expression by northern blotting
(data not shown). Aiming at characterizing our
transfectants, we performed growth curve
experiments on 3 antisense-, 3 sense, 3 control
transfectants and MCF10A parental cells. Even
though antisense transfectants displayed a
significantly higher doubling time than the sense or
the control transfectants, it appeared that sense or
antisense transfection did not importantly alter cell
proliferation (the doubling times were 24.2±1.0;
20.6±1.7; 19.4±2.7 and 19.4±1.7 hours for the
antisense, the sense, the control transfectants and the
parental MCF10A cells, respectively). Also, BrdU
incorporation experiments showed no significant
differences in the percentage of cells incorporating
BrdU between the same 3 sense, 3 antisense and 3
control-vector transfectants when placed in the ring
system (38.1±4.2; 34.3±4.5 and 38.7±5.0% for the
antisense, the sense and the control transfectants,
respectively). A major effect of vimentin sense or
antisense transfection on cell proliferation being
excluded, we examined cell migration of our
transfectants in the ring system. Even though the ring
system gave similar results as the wound healing-
procedure in terms of vimentin expression and
nuclear trajectories it should, however, be mentioned
that the migration speeds of parental MCF10A cells
at the edge of the outgrowth in the ring system were
higher than those observed for cells at the wound’s
edge in the wound-induction procedure (respectively
53.9±10.6 vs 39.0±1.2 m m/hour). Using this system,
we studied in greater details the cell migration
speeds of 4 pooled populations of control-vector
transfectants, 3 pooled populations and 5 clones of
antisense transfectants and 2 pooled populations and
2 clones of sense transfectants in 3 independent
migration experiments. Variance analysis
demonstrated that transfection of MCF10A cells
with the vimentin antisense cDNA significantly
altered (P<0.05) the ability of cells to express
Fig. 6. Effect of EGF on the rapidity of wound closure, vimentin expression
and on cell migration speeds in MCF10A cells. (A,B) Trajectories of 20 cell
nuclei at the wound’s edge of an injured MCF10A monolayer grown in (A)
FCS+EGF-free medium (Control) or in (B) FCS+EGF-free medium
supplemented with EGF at 20 ng/ml (EGF), for 48 hours after wound
induction. The migration speeds calculated from these trajectories are
indicated. (C,D) Vimentin immunolabeling of the corresponding areas. Bars,
80 m m. 
Fig. 7. Reduction of both vimentin expression and cell migration speed by
vimentin antisense transfection. A representative experiment comparing a
vector-control (Control) and a vimentin antisense transfectant (VimAS) is shown
in the figure. (A,B) Trajectories of 20 cell nuclei at the edge of the outgowth of a
control vector pIRES-EGFP-transfected population (Control) and of a vimentin
antisense-transfected clone (VimAS), 72 hours after ring removal. The migration
speeds calculated from these trajectories are indicated. (C,D) Vimentin
immunolabeling of the corresponding areas. Bars, 80 m m. 
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vimentin. In addition, the cell migration speed was
significantly dependent on the transfection (P<0.05) and on
vimentin expression (P<0.05). All the antisense transfectants
indeed expressed less vimentin (with variation from one clone
to another) at the edge of the outgrowth when compared to
MCF10A clones transfected with the control vector. The
antisense-mediated inhibition of vimentin expression in cells
edging the outgrowth coincided with a significantly decreased
migratory speeds compared to the control-vector transfectants
(Fig. 7). The extend of the migration speed slowing clearly
depended on the level of vimentin expression, and attained 40
to 50% in antisense transfectants whose vimentin expression
was the most strongly inhibited. Although sense-vimentin
cDNA-transfected clones and pooled populations
constitutively expressed vimentin independently of their
distance from the edge of the outgrowth, they did not migrate
significantly faster than control transfectants (data not shown).
DISCUSSION
Association of vimentin with epithelial cell migration
In the present study, vimentin expression was examined in
human mammary epithelial MCF10A cells as a function of
their migratory status. Using an in vitro wound healing model,
we clearly showed that vimentin was specifically induced in
the subpopulation of MCF10A cells at the wound’s edge.
Vimentin protein and mRNA were induced in this cell
subpopulation as assessed by immunolabeling and in situ
hybridization, respectively. In support of our in situ
hybridization results, the data obtained with MCF10A cells
transfected with the vimentin promoter controlling the GFP
reporter gene revealed a specific activation of the vimentin
promoter in cells located at the wound’s edge. These results
are in agreement with our and other’s previous results which
have described vimentin expression in epithelial cells involved
in wound healing (SundarRaj et al., 1992; Buisson et al., 1996)
or other processes requiring cell migration (Savagner et al.,
1994; Guarino, 1995; Hay, 1995; Gilles and Thompson, 1996).
Our present data obtained with a cellular model in which
vimentin expression could be induced and studied in relation
with cell migration nevertheless allowed to establish for the
first time a direct relationship between these two functions. The
time-lapse video recordings indeed demonstrated that the
vimentin-expressing subpopulation of MCF10A cells at the
wound’s edge are actively migrating. Also, proliferation
studies excluded the possibility that vimentin expression could
be associated to cell proliferation rather than cell migration. In
addition, the observation that, among cells at the wound’s edge,
those expressing vimentin migrated faster than the scarce
vimentin-negative ones further strengthened the concept that
vimentin is associated with the migratory status. We
accordingly demonstrated that cells distant from the lesion did
not express vimentin, moved erratically without an orientated
trajectory and remained essentially stationary. Furthermore,
MCF10A cells at the wound’s edge formed lamellipodia and
their actin filaments were reorganized, events typical of a
migratory phenotype. Actin reorganization in migrating cells
at the leading front is indeed a key-element in the extension of
lamellipodia associated with cell movements (Welch et al.,
1997). In MCF10A cells at the wound’s edge, actin clearly
formed a rim in extending lamellipodia, a feature previously
described as representative of the migratory phenotype of B16
melanoma cells (Ballestrem et al., 1998). Our findings that
both vimentin expression and directed active cell migration are
concomitantly induced by EGF in cells at the wound edge also
strengthened the theory that vimentin expression in epithelial
cells is associated with the migratory status. Indeed, EGF has
been shown to enhance the migratory properties of some
human epithelial cell lines (Matthay et al., 1993; Solic and
Davies, 1997; Charvat et al., 1998; Murakami et al., 1998) and
several primary human epithelial cell types (Barrandon and
Green, 1987; Stampfer and Bartley, 1988; Chen et al., 1993;
Zahm et al., 1993; Wilson et al., 1994; Moulin, 1995; Andresen
and Ehlers, 1998; Ellerbroek et al., 1998; McCawley et al.,
1998). Even though the regulatory elements involved in the
EGF-activation of the vimentin promotor have not been
identified, several transcription factors, known to be activated
by EGF, are likely to be implicated. The vimentin promotor
indeed contains several binding sites for transcription factors
such as AP-1, members of the ets family or the TCF/LEF-1
transcription factor, shown to promote the EGF-activation of
invasion/migration-associated genes (Rittling et al., 1989;
Lilienbaum and Paulin, 1993; Miller and Moon, 1996; Watabe
et al., 1998; Tomic-Canic et al., 1999). Moreover, some
transcription factors (including PEA-3, a member of the ets
family) have been directly implicated in the differential
regulation of the human vimentin promoter in invasive,
constitutively vimentin-expressing cell lines versus non-
invasive, vimentin-negative human cell lines (Sommers et al.,
1994; Stover et al., 1994; Chen et al., 1996; Moura-Neto et al.,
1996).
Taken together with these data, our findings suggest that the
cells at the the wound’s edge represent a cell subpopulation
with an active migratory phenotype, and that the acquisition of
this phenotype involves or leads to vimentin expression
through activation of the vimentin promoter. The observation
of vimentin’s disappearance after wound closure, further
demonstrates that its expression can be reversed and clearly
suggests that vimentin can be transiently expressed in epithelial
cells concomitantly with their migratory properties.
Functional contribution of vimentin to epithelial cell
migration
Not only does vimentin expression coincide with the migratory
status, but the protein appears to have a functional role in cell
migration as emphasized by our antisense-transfection
experiments. Indeed, evaluating vimentin expression and
quantifying the cell-migration speeds of these transfectants in
the ring system, we found that vimentin antisense transfection
into MCF10A cells led to less vimentin expression in
advancing outgrowth cells. This decreased vimentin induction
was accompagnied by slower migration speeds of these
advancing cells than those of MCF10A cells transfected with
the control vector. In agreement with our findings, Hendrix et
al. (1997) showed that transient transfection of vimentin
antisense oligonucleotides into MDA-MB-231 breast
carcinoma cells (which constitutively express vimentin)
resulted in diminished in vitro invasive properties. Taken
together, all these data clearly demonstrate that interfering with
stable or inducible vimentin expression in epithelial cells
diminish their migratory/invasive potential and therefore
C. Gilles and others
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suggest a functional contribution of vimentin to cell migration.
On the other hand, our sense transfection generated clones
which constitutively expressed vimentin independently of their
migratory status but did not significantly alter the migration
speeds of cells located at the outgrowth’s periphery. This
observation suggests that the endogenous induction of
vimentin in MCF10A cells at the wound’s or outgrowth’s edge
is sufficient to ensure their migration and that overexpressing
vimentin in these cells does not further enhance their migratory
properties. Accordingly, Sommers et al. (1992) did not find any
modifications of the invasiveness of MCF-7 cells transfected
with the human vimentin sense cDNA. Nevertheless, Hendrix
et al. (1997) reported increased invasiveness of stable
vimentin-negative human MCF-7 cells transfected with the
mouse vimentin sense cDNA. It remains therefore
controversial whether forcing vimentin expression in stable
vimentin-negative cells is sufficient to induce invasive
properties. Nonetheless, even though vimentin might not be
sufficient to induce migratory properties in epithelial cells, the
antisense transfection experiments suggest that it could be
functionally involved in, and necessary to epithelial cell
migration.
In apparent contrast with these findings, vimentin knock-
out mice have been shown to develop without any obvious
phenotype (Colucci-Guyon et al., 1994) even though
alterations of the glial fibrillary acidic protein (GFAP)
network have been reported in astrocytes of these mice
(Galou et al., 1996). Compensatory mechanisms are also
likely to occur between vimentin and other intermediate
filament proteins which would participate to the normal
development of these vimentin knockout mice. It has been
recently shown that scar formation in response to spinal or
brain lesions are normal in vimentin or in GFAP knock-out
mice but not in mice deficient for both GFAP and vimentin,
emphasizing a functional overlap between these two proteins
(Pekny et al., 1999). It has nevertheless been suggested that
phenotypic alterations of vimentin-deficient cells could
be distinguished in stress (such as wound healing) or
pathological (such as tumor progression) situations. In
agreement with our data, Eckes et al. (1998) indeed
demonstrated that fibroblasts derived from vimentin-deficient
mice migrated more poorly in a wound-healing system. They
also reported diminished mechanical stability and severely
impaired ability of those fibroblasts to reorganize collagen
fibrils and to contract collagen lattices. Changes of cell shape
and mechanical stability have also been reported by Goldman
et al. (1996) in 3T3 fibroblasts microinjected with peptides
spanning helix-initiation domain 1A of vimentin.
Considering those data obtained with fibroblasts and our
present results with epithelial cells, it can be deduced that
vimentin might also play a functional role in epithelial
cell migration associated with stress or pathological
situations.
Potential contribution of vimentin in epithelial cell
migration
How vimentin could functionally contribute to epithelial cell
migration remains elusive. It has been shown in fibroblasts
that vimentin filaments join the plasma membrane to the
nucleus and might participate in the formation of focal
contacts (Green and Goldman, 1986; Klymkowsky et al.,
1989). Similarly, Eckes et al. (1998) examined fibroblasts
derived from vimentin-deficient mice and reported that the
spatial arrangement of proteins involved in focal contacts
such as vinculin, talin or paxillin was altered. Double
immunofluorescence labeling of quail fibroblasts also showed
that vinculin colocalized with the end of vimentin fibrils
(Bershadsky et al., 1987). Similarly, Seifert et al. (1992)
reported the codistribution of vimentin, vinculin, plectin
(shown to bind vimentin in vitro) and focal contacts in rat
glioma cells. Vimentin has also been implicated as a
mechanical transducer between cell-surface integrins and
endothelial cell nuclei (Maniotis et al., 1997). Furthermore,
vimentin was also shown to interact with microfilaments and
microtubules (Goldman et al., 1986; Seifert et al., 1992;
Draberova and Draber, 1993; Svitkina et al., 1996). Indeed,
it has been reported that vimentin interacted with
detyrosinated microtubules in the leading edge of migrating
fibroblasts in an in vitro wound healing system (Gurland and
Gundersen, 1995). A concomitant redistribution of vimentin
and actin filaments was also described in PDGF-treated
endothelial cells (Valgeirsdottir et al., 1998). All these data
suggest a role for vimentin in the mechanotransduction of
signals via integrins, but also in the overall organization and
integrity of the cytoskeleton which are crucial for the control
of shape, motility and migration of mesenchymal cells. Our
demonstration of a reorganization of actin filaments in
vimentin-expressing cells at the wound’s edge is in agreement
with those data. However, we could not establish a direct
relationship between actin reorganization and the presence of
vimentin, since some vimentin-negative cells exhibited the
same actin distribution as the vimentin-positive ones.
Whether vimentin in epithelial cells involves mechanisms
similar than those described above for fibroblasts or
endothelial cells thus remains to be ascertained and is under
investigation. 
Taken together, our results clearly demonstrate that vimentin
expression in epithelial MCF10A cells is closely related to
their migratory status. Vimentin expression was indeed
induced exclusively in cells at the wound’s edge which are
involved in directed migration towards the center of the lesion.
The disappearance of vimentin after wound closure also
suggests that this phenomenon is reversible and that vimentin
expression is transiently associated with the migratory status.
Our antisense-transfection experiments further suggest that
vimentin may play a functional role in cell migration.
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